Barry Jones

Barry Jones is an experienced professional in the field of biomarker bioanalysis and LC-MS biologics, currently serving as Director at Crinetics Pharmaceuticals since November 2022. Prior to this role, Barry held various leadership positions at Q² Solutions from October 2016 to November 2022, including Director and Associate Director of LC-MS Biologics and Biomarkers. Barry's career began at Quintiles, where responsibilities included Assistant Research Investigator for LC/MS Biologics from June 2007 to October 2016. Additionally, Barry worked as a Research Chemist at Binghamton University from June 2005 to April 2007. Barry earned a Doctor of Philosophy (Ph.D.) in Physical Chemistry from Binghamton University, completing the degree in 2007.